Catalyst Pharmaceuticals, Inc. (CPRX)
24.82
+0.06
(+0.24%)
USD |
NASDAQ |
Apr 01, 16:00
25.04
+0.22
(+0.89%)
After-Hours: 20:00
Catalyst Pharmaceuticals Research and Development Expense (TTM) : 12.71M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| ADMA Biologics, Inc. | 4.761M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Inovio Pharmaceuticals, Inc. | 52.42M |
| Ionis Pharmaceuticals, Inc. | 914.12M |
| Karyopharm Therapeutics, Inc. | 125.32M |